Investment
Features
FeesSafety
Academy
More
Pluang+

Compare EHang Holdings Ltd - ADR (EH) vs Medtronic PLC (MDT) Price & Performance

EHang Holdings Ltd - ADRTrade
Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

EHang Holdings Ltd - ADR vs Medtronic PLC — how do they compare? EHang Holdings Ltd - ADR trades at $5.46 (market cap $414.87M), while Medtronic PLC trades at $83.27 (market cap $103.01B). The key difference: Medtronic PLC is far larger — about 248.3× EHang Holdings Ltd - ADR's market cap, and Medtronic PLC pays a 3.58% dividend while EHang Holdings Ltd - ADR pays none. Which is the better fit depends on your goals.

EHMDT
Market Cap
$414.87M$103.01B
Sector
IndustrialsHealth
52-Week High
$19.99$105.35
52-Week Low
$5.41$73.75
Enterprise Value
$354.54M$121.75B
Dividend Yield
3.58%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

EHang Holdings Ltd - ADR

EHang Holdings (EH) trades at $5.56, up 2.02% on the day, amid mixed technical and fundamental signals. The stock shows a bearish technical trend with oversold short-term RSI, while fundamentally, the company reported Q1 2026 revenue of $418M, flat year-over-year but sharply lower sequentially due to delivery timing. The company remains unprofitable with a net margin of -77.56% and negative ROE of -34.03%, though it maintains a strong cash position of $1.12B and recently announced a $30M share repurchase program.

The outlook is bifurcated between significant long-term potential in the advanced air mobility market and near-term execution and profitability challenges. Investment opportunity lies in the company's first-mover technology and global regulatory progress, but risks include persistent cash burn, high valuation multiples despite losses, and intense competition in the emerging eVTOL sector. Analyst consensus is divided with a $6.97 price target but equal buy/hold/sell ratings.

Medtronic PLC

Medtronic (MDT) trades at $79.30, down 5.11% over 24 hours, with technical indicators showing bearish momentum. Fundamentally, the company reported strong earnings beats for three consecutive quarters and maintains solid profitability with a 13.2% net income margin. Recent news highlights the completion of the Scientia Vascular acquisition and bullish analyst coverage citing undervaluation and growth in cardiovascular and neuroscience segments.

The stock presents a compelling opportunity with a consensus price target of $97.50 representing 23% upside, supported by 58% analyst buy ratings. Key risks include increasing debt-to-asset ratios (31.11% in 2025) and margin pressures from tariffs and foreign exchange. The dividend aristocrat offers a near-decade high yield with consistent dividend growth.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About EHang Holdings Ltd - ADR

EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.

Read more on EH

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT